Skip to main content

Sanofi Opens its First Digitally-Enabled, Continuous Biologics Manufacturing Facility

 

One of the first digital manufacturing facilities in the world to use continuous, intensified biologics production technology.

Sanofi celebrates the inauguration of its new digital manufacturing facility in Framingham, Massachusetts, marking one of the world’s first digital facilities using intensified, continuous biologics production technology.

The new facility features leading-edge technology that connects the production process with research and development, paving the way for improved commercialization of important new medicines for patients.